Additional information
by Mary Claire Haver (Author)
Filling a gaping hole in menopause care, everything a woman needs to know to thrive during her hormonal transition and beyond, as well as the tools to help her take charge of her health at this pivotal life stage--by the bestselling author of The Galveston Diet.
Menopause is inevitable, but suffering through it is not! This is the empowering approach to self-advocacy that pioneering women's health advocate Dr. Mary Claire Haver takes for women in the midst of hormonal change in The New Menopause. A comprehensive, authoritative book of science-backed information and lived experience, it covers every woman's needs:- From changes in your appearance and sleep patterns to neurological, musculoskeletal, psychological, and sexual issues, a comprehensive A to Z toolkit of science-backed options for coping with symptoms.
- What to do to mediate the risks associated with your body's natural drop in estrogen production, including for diabetes, dementia, Alzheimer's, osteoporosis, cardiovascular disease, and weight gain.
- How to advocate and prepare for annual midlife wellness visits, including questions for your doctor and how to insist on whole life care.
- The very latest research on the benefits and side effects of hormone replacement therapy.
Arming women with the power to secure vibrant health and well-being for the rest of their lives, The New Menopause is sure to become the bible of midlife wellness for present and future generations.
Author Biography
Mary Claire Haver, MD, is a board-certified OB/GYN, a Certified Culinary Medicine Specialist, a Certified Menopause Provider, and the founder of Mary Claire Wellness, a private medical practice that focuses on women in midlife. Her bestselling book, The Galveston Diet, is based on the groundbreaking nutritional protocol she developed as an online subscriber program for women going through perimenopause and menopause. She lives in Galveston, Texas.
Number of Pages: 320
Dimensions: 1.34 x 9.13 x 6.3 IN
Publication Date: April 30, 2024
